Medical News Summary: Drug approved for treatment of diabetic peripheral neuropathy


About: Drug approved for treatment of diabetic peripheral neuropathy
Date: 21 October 2004
Source: Onlypunjab
Medical News Summary (summary of medical news story as reported by Onlypunjab): Cymbalta has been recently approved by the FDA for use in pain management for sufferers of diabetic peripheral neuropathy. 62% of diabetic patients will develop this condition and is associated with sensations of burning, tingling and numbness. Clinical trials of the product have shown significant pain relief in many and the main side effects were nausea, dry mouth, constipation, diarrhea, dizziness and hot flashes.
Related Disease Topics: Diabetes, Peripheral neuropathy
Related Symptom Topics: Nausea, dry mouth, constipation, diarrhea, dizziness, hot flashes, burning, tingling and numbness

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

Medical Tools & Articles:

Next articles:

Medical Articles:
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise